OptiMATe: De-escalated Induction Treatment in Primary CNS Lymphoma
OptiMATe: De-escalated Induction Treatment in Primary CNS Lymphoma
Active, not recruiting · NCT04931368 · Registry updated 2026-03-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| OptiMATe: De-escalated Induction Treatment in Primary CNS Lymphoma | primary central nervous system lymphoma | Active, not recruiting | Phase 3 | 2026-03-18 | NCT04931368 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| German Federal Ministry of Education and Research | 30 |
| Klinikum Stuttgart | 6 |
| University Hospital Freiburg | 38 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Klinikum Stuttgart | Stuttgart | Germany | 2 |